Health services use and health care costs of obese and nonobese individuals.

BACKGROUND Obesity has clinical and economic consequences. Few studies have compared health care resource utilization between age- and sex-matched obese and nonobese persons. METHODS We conducted a retrospective study in obese and nonobese individuals matched by age, sex, medical clinic, and selected exclusionary diagnoses. Data collected included hospitalizations, outpatient visits, professional claims, and prescriptions over 1 year. Costs were assigned to medical resources based on market prices using publicly available costs. Comorbid conditions were determined using a chronic disease score (CDS) index. Groups were compared on types and costs of resources consumed. Regression models were used to examine the effect of body mass index (BMI) on costs while controlling for age and chronic diseases. RESULTS A total of 539 obese and 1225 nonobese persons were examined. Obese patients had more hospitalizations (P<.001), prescription drugs (P<.001), professional claims (P<.001), and outpatient visits (P = .005). Obese patients used more cardiovascular, intranasal allergic rhinitis, asthma, ulcer, diabetes, thyroid, and analgesic drugs. Total costs between groups were different (median of $585.44 for obese and $333.24 for nonobese patients; P<.001). Cost differences were primarily due to medications (P<.001). Predictors of total costs were age, sex, BMI, and CDS. For each unit BMI increase, costs increased 2.3% (P<.001). For each CDS unit increase, costs increased 52.9% (P<.001). CONCLUSION Over 1 year, health care costs for obese persons are higher than for nonobese persons, primarily because of prescription drugs.

[1]  D. Allison,et al.  Years of life lost due to obesity. , 2003, JAMA.

[2]  N. Breslow,et al.  Statistical methods in cancer research: volume 1- The analysis of case-control studies , 1980 .

[3]  R. Sturm,et al.  The effects of obesity, smoking, and drinking on medical problems and costs. , 2002, Health affairs.

[4]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2000. , 2002, JAMA.

[5]  Markku Peltonen,et al.  Long-term effects of weight loss on pharmaceutical costs in obese subjects. A report from the SOS intervention study , 2002, International Journal of Obesity.

[6]  K. Berk,et al.  Repeated measures with zeros , 2002, Statistical methods in medical research.

[7]  G. Oster,et al.  The clinical and economic burden of obesity in a managed care setting. , 2000, The American journal of managed care.

[8]  Pi-Sunyer Fx.  Short-Term Medical Benefits and Adverse Effects of Weight Loss , 1993 .

[9]  G A Colditz,et al.  Current estimates of the economic cost of obesity in the United States. , 1998, Obesity research.

[10]  Update: prevalence of overweight among children, adolescents, and adults--United States, 1988-1994. , 1997, MMWR. Morbidity and mortality weekly report.

[11]  D. Harville.  Maximum Likelihood Approaches to Variance Component Estimation and to Related Problems , 1977 .

[12]  G. Oster,et al.  Body mass index and future healthcare costs: a retrospective cohort study. , 2001, Obesity research.

[13]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[14]  F. Pi‐Sunyer,et al.  Medical Hazards of Obesity , 1993, Annals of Internal Medicine.

[15]  Berk Kn,et al.  Repeated measures with zeros. , 2002 .

[16]  G. Oster,et al.  Lifetime health and economic benefits of weight loss among obese persons. , 1999, American journal of public health.

[17]  N. Breslow,et al.  Statistical methods in cancer research. Vol. 1. The analysis of case-control studies. , 1981 .

[18]  G. Colditz,et al.  The cost of obesity: the US perspective. , 1994, PharmacoEconomics.

[19]  C. Quesenberry,et al.  Obesity, health services use, and health care costs among members of a health maintenance organization. , 1998, Archives of internal medicine.

[20]  M. Raebel,et al.  The Long-term Outcomes of Sibutramine Effectiveness on Weight (LOSE Weight) study: evaluating the role of drug therapy within a weight management program in a group-model health maintenance organization. , 2004, The American journal of managed care.

[21]  Gregory E. Simon,et al.  A Chronic Disease Score with Empirically Derived Weights , 1995, Medical care.

[22]  G A Colditz,et al.  Lifetime health and economic consequences of obesity. , 1999, Archives of internal medicine.

[23]  K. Narayan,et al.  The direct health care costs of obesity in the United States. , 1999, American journal of public health.

[24]  Claude Bouchard,et al.  Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. , 1998, WMJ : official publication of the State Medical Society of Wisconsin.

[25]  W N Burton,et al.  The economic costs associated with body mass index in a workplace. , 1998, Journal of occupational and environmental medicine.

[26]  Markku Peltonen,et al.  Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: the SOS intervention study. , 2002, Archives of internal medicine.

[27]  David R. Cox.  The analysis of binary data , 1970 .

[28]  Abdullah Al Mamun,et al.  Obesity in Adulthood and Its Consequences for Life Expectancy: A Life-Table Analysis , 2003, Annals of Internal Medicine.

[29]  M. Kendall.  Theoretical Statistics , 1956, Nature.

[30]  C P Farrington,et al.  Relative incidence estimation from case series for vaccine safety evaluation. , 1995, Biometrics.